Skip to main content
SpringerLink
Log in

Tumors of the Pleura

  • Chapter
  • First Online:
Diagnostic Pathology of Pleuropulmonary Neoplasia

  • 1732 Accesses

Abstract

The gamut of neoplastic and pseudoneoplastic conditions that may seed the pleural surface is extensive and can be divided into primary and metastatic neoplasm. In addition, the pleura may be the site for tumors of different lineage including epithelial, mesenchymal, neural, and neuroectodermal, as well as lymphoid neoplasms. However, in order to properly assess the origin of lesions seeding the pleural surface, it is important to properly correlate findings with imaging studies, which can be of important aid in addressing issues such as extent of disease and possible origin. In this chapter, the emphasis will be in primary pleural lesions leaving the issue of metastatic disease in the context of differential diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Own observations. Unreported data.

References

  1. Hinds MW. Mesothelioma in the United States: incidence in the 1970s. J Occup Med. 1978;20:469–71.

    PubMed  CAS  Google Scholar 

  2. National Cancer Institute. SEER Cancer Statistics Review ­1975–2003. http://seer.cancer.gov/csr/1975_2003/results_merged/sect_17mesothelioma.pdf. Accessed 3 Jan 2012.

  3. Craighead JE. The epidemiology and pathogenesis of malignant mesothelioma. Chest. 1989;96:92–3.

    Google Scholar 

  4. Wright WE, Sherwin RP. Histological types of malignant mesothelioma and asbestos exposure. Br J Ind Med. 1984;41:514–7.

    PubMed  CAS  Google Scholar 

  5. Borow M, Conston A, Livornese L, et al. Mesothelioma following exposure to asbestos: a review of 72 cases. Chest. 1973;64:641–6.

    PubMed  CAS  Google Scholar 

  6. Wagner E. Das tuberkelähnliche Lymphadenom. Arch F Heilk. 1870;11:497–525.

    Google Scholar 

  7. Robertson HE. Endothelioma of the pleura. J Cancer Res. 1923–1924;8:317.

    Google Scholar 

  8. Klemperer P, Rabin CB. Primary neoplasms of the pleura. Arch Pathol. 1931;11:385–412.

    Google Scholar 

  9. DuBray ES, Rosson FB. Primary mesothelioma of the pleura: a clinical and pathological contribution to the pleural malignancy, with report of a case. Arch Intern Med. 1920;26:715–37.

    Google Scholar 

  10. Godwin MC. Diffuse mesotheliomas: with comment on their relation to localized fibrous mesotheliomas. Cancer. 1957;10:298–319.

    PubMed  CAS  Google Scholar 

  11. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Town province. Br J Ind Med. 1960;17:260–71.

    PubMed  CAS  Google Scholar 

  12. Hirsch A, Brochard P, Cremoux H, et al. Features of asbestos-exposed and unexposed mesothelioma. Am J Ind Med. 1982;3:413–22.

    PubMed  CAS  Google Scholar 

  13. McCaughey WTE. Criteria for the diagnosis of diffuse mesothelial tumors. Ann N Y Acad Sci. 1965;132:603–13.

    PubMed  CAS  Google Scholar 

  14. Huncharek M, Kelsey K, Mark EJ, et al. Treatment and survival in diffuse malignant pleural mesothelioma: a study of 83 cases from Massachusetts General Hospital. Anticancer Res. 1996;16:1265–8.

    PubMed  CAS  Google Scholar 

  15. Aaisner J, Wiernik PH. Malignant mesothelioma: current status and future prospects. Chest. 1978;74:438–44.

    Google Scholar 

  16. Gardner MJ, Acheson ED, Winter PD. Mortality from mesothelioma of the pleura during 1968–78 in England and Wales. Br J Cancer. 1982;46:81–8.

    PubMed  CAS  Google Scholar 

  17. Oels HC, Harrison EG, Carr DT, Bernatz PE. Diffuse malignant mesothelioma of the pleura: a review of 37 cases. Chest. 1971;60:564–70.

    PubMed  CAS  Google Scholar 

  18. Chahinian AP, Pajak TF, Holland JF, et al. Diffuse malignant mesothelioma: prospective evaluation of 69 patients. Ann Intern Med. 1982;96:746–55.

    PubMed  CAS  Google Scholar 

  19. Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant mesothelioma of the pleura: review of 123 patients. Cancer. 1982;49:2431–5.

    PubMed  CAS  Google Scholar 

  20. Law MR, Hodson ME, Heard BE. Malignant mesothelioma of the pleura: relation between histological type and clinical behavior. Thorax. 1982;37:810–5.

    PubMed  CAS  Google Scholar 

  21. Qua JC, Rao UMN, Takita H. Malignant pleural mesothelioma: a clinicopathological study. J Surg Oncol. 1993;54:47–50.

    PubMed  CAS  Google Scholar 

  22. Suzuki Y. Pathology of human malignant mesothelioma. Semin Oncol. 1980;8:268–82.

    Google Scholar 

  23. Grundy GW, Miller RW. Malignant mesothelioma in childhood: report of 13 cases. Cancer. 1972;30:1216–8.

    PubMed  CAS  Google Scholar 

  24. Moran CA, Suster S, Albores-Saavedra J. Peritoneal mesotheliomas in children: a clinicopathologic study of 8 cases. Histopathology. 2008;52:824–30.

    PubMed  CAS  Google Scholar 

  25. Peterson JT, Greenberg DS, Buffler PA. Non-asbestos related malignant mesothelioma. A review. Cancer. 1984;54:951–60.

    PubMed  Google Scholar 

  26. Crotty TB, Myers JL, Katzenstein AL, et al. Localized malignant mesothelioma. A clinicopathologic and flow cytometric study. Am J Surg Pathol. 1994;18:357–63.

    PubMed  CAS  Google Scholar 

  27. Ordoñez NG. Epithelial mesothelioma with deciduoid features: report of four cases. Am J Surg Pathol. 2000;24:816–23.

    PubMed  Google Scholar 

  28. Ordoñez NG, Mackay B. Clear cell mesothelioma. Ultrastruct Pathol. 1996;20:331–6.

    PubMed  Google Scholar 

  29. Henderson DW, Attwood HD, Constance TJ, Shilkin KB, Steele RH. Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultrastruct Pathol. 1988;12:367–84.

    PubMed  CAS  Google Scholar 

  30. Yousem SA, Hochholzer L. Malignant mesothelioma with osseous and cartilaginous differentiation. Arch Pathol Lab Med. 1987;111:62–6.

    PubMed  CAS  Google Scholar 

  31. Weissferdt A, Kalhor N, Suster S. Malignant mesothelioma with prominent adenomatoid features: a clinicopathological and immunohistochemical study of 10 cases. Ann Diagn Pathol. 2011;15:25–9.

    PubMed  Google Scholar 

  32. Arrossi AV, Lin E, Rice D, Moran CA. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy. Am J Clin Pathol. 2008;130:754–64.

    PubMed  Google Scholar 

  33. Moran CA, Wick MR, Suster S. The role of immunohistochemistry in the diagnosis of malignant mesothelioma. Semin Diagn Pathol. 2000;17:178–83.

    PubMed  CAS  Google Scholar 

  34. Suster S, Moran CA. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol. 2006;13:316–29.

    PubMed  CAS  Google Scholar 

  35. Wick MR, Moran CA, Mills SE, Suster S. Immunohistochemical differential diagnosis of pleural effusions with emphasis on malignant mesothelioma. Curr Opin Pulm Med. 2001;7:187–92.

    PubMed  CAS  Google Scholar 

  36. Ordonez NG. Valued of cytokeratin 5/6 immunostain in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol. 1998;22:1215–21.

    PubMed  CAS  Google Scholar 

  37. Ordonez NG. In search for a positive immunohistochemical marker for mesothelioma: an update. Adv Anat Pathol. 1998;5:53–60.

    PubMed  CAS  Google Scholar 

  38. Moll R, Dhouailly D, Sun TT. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas: an immunohistochemical study using monoclonal antibody AE14. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;58:129–45.

    PubMed  CAS  Google Scholar 

  39. Clover J, Oates J, Edwards C. Anti-cytokeratin 5/6: a potential marker for epithelioid mesothelioma. Histopathology. 1997;31:140–3.

    PubMed  CAS  Google Scholar 

  40. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol. 2002;15:6–10.

    PubMed  Google Scholar 

  41. Gotzos V, Vogt P, Celio MR. The calcium binding protein calretinin is a selective marker for malignant mesothelial proliferation using formalin-fixed paraffin sections. J Pathol. 1992;192:137–47.

    Google Scholar 

  42. Dogliioni C, dei Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol. 1996;20:1037–46.

    Google Scholar 

  43. Dei Tos AP, Doglioni C. Calretinin: a novel tool for diagnostic immunohistochemistry. Adv Anat Pathol. 1998;5:61–6.

    Google Scholar 

  44. Oates J, Edwards C. HBME-1, MOC31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology. 2000;36:341–7.

    PubMed  CAS  Google Scholar 

  45. Foster MR, Johnson JE, Olson SJ, et al. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesothelioma and primary pulmonary adenocarcinoma. Arch Pathol Lab Med. 2001;125:1316–20.

    PubMed  CAS  Google Scholar 

  46. Kuman-Sing S, Segers K, Rodeck U, et al. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell type transition and prognosis. J Pathol. 1997;181:67–74.

    Google Scholar 

  47. Yazjii H, Battifora H, Barry TS, et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol. 2006;19:514–23.

    Google Scholar 

  48. Amin KM, Litzky LA, Smythe RW, et al. Wilm’s tumor −1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol. 1995;146:344–56.

    PubMed  CAS  Google Scholar 

  49. Walker C, Rutten F, Yuan X, et al. Wilms’ tumor suppressor gene expression in rat and human mesothelioma. Cancer Res. 1994;54:3101–6.

    PubMed  CAS  Google Scholar 

  50. Ordonez NG. The value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol. 2000;24:598–606.

    PubMed  CAS  Google Scholar 

  51. Miettinen M, Kovatich AJ. HMBE-1 – a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft tissue and bone tumors. Appl Immunohistochem. 1995;3:115–22.

    Google Scholar 

  52. Kennedy AD, King G, Kerr KM. HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of the pleura. J Clin Pathol. 1997;50:859–62.

    PubMed  CAS  Google Scholar 

  53. Attanoos RL, Goddard H, Gibbs AR. Mesothelioma-binding antibodies: thrombomodulin, OV632, and HBME-1 and their use for the diagnosis of malignant mesothelioma. Histopathology. 1996;29:209–15.

    PubMed  CAS  Google Scholar 

  54. Collins CL, Ordonez SG, Schaefer R, et al. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol. 1992;141:827–33.

    PubMed  CAS  Google Scholar 

  55. Ascoli V, Scalso CC, Taccogna S, et al. the diagnostic value of thrombomodulin immunolocalization in serous effusions. Arch Pathol Lab Med. 1995;119:1136–40.

    PubMed  CAS  Google Scholar 

  56. Argani P, Iacobuziio-Donahue C, Ryu B, et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression. Clin Cancer Res. 2001;7:3862–8.

    PubMed  CAS  Google Scholar 

  57. Ordonez NG. Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol. 2003;27:1418–28.

    PubMed  Google Scholar 

  58. Hassan R, Kreitman RJ, Pastan I, et al. Localization of mesothelin in epithelial ovarian cancer. Appl Immunohistochem Mol Morphol. 2005;13:243–7.

    PubMed  CAS  Google Scholar 

  59. Cao D, Ji H, Ronnett BM. Expression of mesothelin, fascin, prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary. Int J Gynecol Pathol. 2005;24:67–72.

    PubMed  Google Scholar 

  60. Comin CE, Novelli L, Boddi V, et al. Calretinin, thrombomodulin, CEA, and CD-15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. Hum Pathol. 2001;32:529–36.

    PubMed  CAS  Google Scholar 

  61. Garcia-Prats MD, Ballestin C, Sotelo T, et al. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumors. Histopathology. 1998;32:462–72.

    PubMed  CAS  Google Scholar 

  62. Roberts F, Harper CM, Downie I, et al. Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma: a study of thirteen antibodies. Am J Clin Pathol. 2001;116:253–62.

    PubMed  CAS  Google Scholar 

  63. Leosli H, Hurliman J. Immunohistochemical study of malignant diffuse mesothelioma of the pleura. Histopathology. 1984;8:793–803.

    Google Scholar 

  64. Battifora H, Kopinsky M. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer. 1985;55:1679–85.

    PubMed  CAS  Google Scholar 

  65. Pfaltz M, Odermatt B, Christen B, et al. Immunohistochemistry in the diagnosis of malignant mesothelioma. Virchows Arch. 1987;411:387–93.

    CAS  Google Scholar 

  66. Otis CN, Carter D, Cole S, et al. Immunnohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. Am J Surg Pathol. 1987;11:445–56.

    PubMed  CAS  Google Scholar 

  67. Wharhol MJ. The ultrastructural localization of keratin proteins and carcinoembryonic antigen in malignant mesothelioma. Am J Pathol. 1984;116:385–90.

    Google Scholar 

  68. Sosolik RC, McGauhy VR, De Young BR. Anti-MOC31: a potential addition to the pulmonary adenocarcinoma versus mesothelioma immunohistochemistry panel. Mod Pathol. 1997;10:716–9.

    PubMed  CAS  Google Scholar 

  69. Ordonez NG. The value of MOC31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. Hum Pathol. 1998;29:166–9.

    PubMed  CAS  Google Scholar 

  70. Gonzalez-Lois C, Ballentin C, Sotelo M, et al. Combined use of novel epithelial (MOC31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura. Histopathology. 2001;38:528–34.

    PubMed  CAS  Google Scholar 

  71. Di Loreto C, Pubglisi F, Di Lauro V, et al. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Lett. 1998;13:73–8.

    Google Scholar 

  72. Bakir K, Kocer NE, Deniz H, et al. TTF-1 and surfactant-B as co-adjuvants in the diagnosis of adenocarcinoma and pleural mesothelioma. Ann Diagn Pathol. 2004;8:337–41.

    PubMed  Google Scholar 

  73. Khoor A, Whitset JA, Stahlman MT, et al. Utility of surfactant protein B precursor and thyroid transcription factor-1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol. 1999;30:695–700.

    PubMed  CAS  Google Scholar 

  74. Skov BG, Lauritzen AF, Hirsch FR, et al. Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies. Histopathology. 1993;25:431–7.

    Google Scholar 

  75. Moch H, Oberholzer M, Christen H, et al. Diagnostic tools for differentiating pleural mesothelioma from lung adenocarcinoma in paraffin embedded tissue. Part II. Virchows Arch A. 1993;423:493–6.

    CAS  Google Scholar 

  76. Brown RW, Clark GM, Tandon AK, et al. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol. 1993;24:347–54.

    PubMed  CAS  Google Scholar 

  77. Jordon D, Jagirdar J, Kaneko M. Blood group antigens, Lewis and Lewis, in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma. Am J Pathol. 1989;135:931–7.

    PubMed  CAS  Google Scholar 

  78. Ordonez NG. Mesotheliomas with crystalloid structures: report of nine cases, including one with oncocytic features. Mod Pathol. 2012;25:272–81.

    PubMed  Google Scholar 

  79. Carter D, Otis CN. Three types of spindle cell tumors of the pleura. Fibroma, sarcoma, and sarcomatoid mesothelioma. Am J Surg Pathol. 1988;12:747–53.

    PubMed  CAS  Google Scholar 

  80. Kannerstein M, Churg J. Desmoplastic diffuse malignant mesothelioma. In: Fenoglio CM, Wolff M, editors. Progress in surgical pathology, vol. 11. New York: Masson Publishing; 1980. p. 19–29.

    Google Scholar 

  81. Cantin R, al-Jabi M, McCaughey WTE. Desmoplastic diffuse mesothelioma. Am J Surg Pathol. 1982;6:215–22.

    PubMed  CAS  Google Scholar 

  82. Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL. The diagnosis of desmoplastic malignant mesothelioma and its ­distinction from fibrous pleurisy. Am J Clin Pathol. 1998;110:191–9.

    PubMed  CAS  Google Scholar 

  83. Colby TV. The diagnosis of desmoplastic malignant mesothelioma. Am J Clin Pathol. 1998;110:135–6.

    PubMed  CAS  Google Scholar 

  84. Henderson DW. Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultrastruct Pathol. 1988;12:367–84.

    PubMed  CAS  Google Scholar 

  85. Rice D. Surgery for malignant pleural mesothelioma. Ann Diagn Pathol. 2009;13(1):65–72.

    PubMed  Google Scholar 

  86. Harwood TR, Gracey DR, Yokoo H. Pseudomesotheliomatous carcinoma of the lung: a variant of peripheral lung cancer. Am J Clin Pathol. 1976;65:159–67.

    PubMed  CAS  Google Scholar 

  87. Koss MN, Travis W, Moran C, Hochholzer L. Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol. 1992;9:117–23.

    PubMed  CAS  Google Scholar 

  88. Nishimoto Y, Ohno T, Saito K. Pseudomesotheliomatous carcinoma of the lung with histochemical and immunohistochemical study. Acta Pathol Jpn. 1983;33:415–23.

    PubMed  CAS  Google Scholar 

  89. Dessy E, Pietra G. Pseudomesotheliomatous carcinoma of the lung: an immunohistochemical and ultrastructural study of three cases. Cancer. 1991;68:1747–53.

    PubMed  CAS  Google Scholar 

  90. Shah I, Salvatore JR, Kummet T, et al. Pseudomesotheliomatous carcinoma involving pleura and peritoneum: a clinicopathological and immunohistochemical study of three cases. Ann Diagn Pathol. 1999;3:148–59.

    PubMed  CAS  Google Scholar 

  91. Attanos RL, Gibbs AR. Pseudomesotheliomatous carcinomas of the pleura: a 10-year analysis of cases from the environmental lung disease research group, Cardiff. Histopathology. 2003;43:444–52.

    Google Scholar 

  92. Koss MN, Fleming M, Pzygodski RM, et al. Adenocarcinoma simulating mesothelioma: a clinicopathological and immunohistochemical study of 29 cases. Ann Diagn Pathol. 1999;3:148–59.

    Google Scholar 

  93. Pardo J, Torres W, Martinez-Penuela A, et al. Pseudomesotheliomatous carcinoma of the lung with distinct morphology, immunohistochemistry, and comparative genomic hybridization profile. Ann Diagn Pathol. 2007;11:241–51.

    PubMed  Google Scholar 

  94. Moran CA, Suster S. Primary mucoepidermoid carcinoma of the pleura: a clinicopathological study of two cases. Am J Surg Pathol. 2003;120:381–5.

    Google Scholar 

  95. Asa SL, Dardick I, Van Nostrand PAW, et al. Primary thyroid thymoma: a distinct clinicopathologic entity. Hum Pathol. 1988;19:1463–6.

    PubMed  CAS  Google Scholar 

  96. Martin JME, Randhawa G, Temple WJ. Cervical thymoma. Arch Pathol Lab Med. 1986;110:354–7.

    PubMed  CAS  Google Scholar 

  97. Yamashita H, Murakami N, Noguchi S, et al. Cervical thymoma. Acta Pathol Jpn. 1983;33:189–94.

    PubMed  CAS  Google Scholar 

  98. Wadon A. Thymoma intratracheal. Am J Pathol. 1934;60:308–12.

    Google Scholar 

  99. Moran CA, Suster S, Fishback NF, Koss MN. Intrapulmonary thymoma: a clinicopathologic correlation of eight cases. Am J Surg Pathol. 1995;19:304–12.

    Google Scholar 

  100. Payne CB, Mornigstar WA, Chester EH. Thymoma of the pleura masquerading as diffuse mesothelioma. Am Rev Respir Dis. 1960;94:441–6.

    Google Scholar 

  101. Honma K, Shimada K. Metastasizing ectopic thymoma arising in the right thoracic cavity and mimicking diffuse pleural mesothelioma. An autopsy study of a case with review of the literature. Wien Klin Wochenschr. 1986;98:14–20.

    PubMed  CAS  Google Scholar 

  102. Moran CA, Travis WD, de-Christenson M, Koss MN, Rosai J. Thymomas presenting as pleural tumors: report of eight cases. Am J Surg Pathol. 1992;16:138–44.

    PubMed  CAS  Google Scholar 

  103. Vural M, Abali H, Oksuzog B, Akbulut M. An atypical presentation of thymoma with diffuse pleural dissemination mimicking mesothelioma. Cancer Invest. 2006;24:615–20.

    PubMed  Google Scholar 

  104. Qing G, Ionescu DN, Colby TV, Leslie KO. A 75-year-old man with an asymptomatic pleural-based mass discovered on routine chest radiographs. Primary pleural thymoma. Arch Pathol Lab Med. 2006;130:e62–5.

    PubMed  Google Scholar 

  105. Kim HS, Lee HJ, Cho SY, et al. Myasthenia gravis in ectopic thymoma presenting as pleural masses. Lung Cancer. 2007;57:115–57.

    PubMed  Google Scholar 

  106. Yamazaki K, Yoshino I, Oba T, et al. Ectopic pleural thymoma presenting as a giant mass in the thoracic cavity. Ann Thorac Surg. 2007;83:315–7.

    PubMed  Google Scholar 

  107. Shin DF, Wang JS, Tseng HH, Tiao VM. Primary pleural thymoma. Arch Pathol Lab Med. 1997;1221:79–82.

    Google Scholar 

  108. Higasiyama M, Doi O, Kodama K, et al. Ectopic primary thymoma: report of a case. Surg Today. 1996;26:747–50.

    Google Scholar 

  109. Fushimi H, Tanio Y, Koth K. Ectopic thymoma mimicking diffuse pleural mesothelioma: a case report. Hum Pathol. 1998;29:409–10.

    PubMed  CAS  Google Scholar 

  110. Plaza JA, Dominguez F, Suster S. Cystic adenomatoid tumor of the mediastinum. Am J Surg Pathol. 2004;28:132–8.

    Google Scholar 

  111. Ikuta N, Tano M, Iwata M, et al. A case of adenomatoid mesothelioma of the pleura. Jpn J Thorac Dis. 1989;27:1540–4.

    CAS  Google Scholar 

  112. Kaplan MA, Tazelaar HD, Hayashi T, et al. Adenomatoid tumors of the pleura. Am J Surg Pathol. 1996;20:1219–23.

    PubMed  CAS  Google Scholar 

  113. Flieder D, Moran CA, Travis WD, et al. Pleuro-pulmonary endometriosis and pulmonary ectopic deciduosis: a clinicopathologic and immunohistochemical study of 10 cases with emphasis in diagnostic pitfalls. Hum Pathol. 1998;12:1495–503.

    Google Scholar 

  114. Karpel JP, Appel D, Merav A. Pulmonary endometriosis. Lung. 1985;163:151–9.

    PubMed  CAS  Google Scholar 

  115. Lattes R, Shepard F, Tovell H, et al. A clinical and pathological study of endometriosis of the lung. Surg Gynecol Obstet. 1956;103:552–8.

    PubMed  CAS  Google Scholar 

  116. Foster DC, Stern JL, Buscema J, et al. Pleural and parenchyma pulmonary endometriosis. Obstet Gynecol. 1981;58:552–6.

    PubMed  CAS  Google Scholar 

  117. Austin MB, Frierson HF, Fechner RE, et al. Endometrioma of the lung presenting as hemoptysis and a large pulmonary mass. Surg Pathol. 1988;1:165–9.

    Google Scholar 

  118. Witkin GB, Rosai J. Solitary fibrous tumor of the mediastinum. Report of 14 cases. Am J Surg Pathol. 1989;13:547–57.

    PubMed  CAS  Google Scholar 

  119. Goodlad JR, Fletcher CDM. Solitary fibrous tumor arising at unusual sites: analysis of a series. Histopathology. 1991;19:512–22.

    Google Scholar 

  120. Dorfman DM, To K, Dickersin GR, et al. Solitary fibrous tumor of the orbit. Am J Surg Pathol. 1994;18:281–7.

    PubMed  CAS  Google Scholar 

  121. Suster S, Nascimiento AG, Miettinen M, et al. Solitary fibrous tumor of soft tissue. A clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol. 1995;19:1257–66.

    PubMed  CAS  Google Scholar 

  122. Scharifker D, Kaneko M. Localized fibrous “mesothelioma” of pleura (submesothelial fibroma): a clinicopathologic study of 18 cases. Cancer. 1979;43:627–35.

    PubMed  CAS  Google Scholar 

  123. Dalton WT, Zolliker AS, McCaughey WTE, et al. Localized primary tumors of the pleura. An analysis of 40 cases. Cancer. 1979;44:1465–75.

    PubMed  CAS  Google Scholar 

  124. Briselli M, Mark EJ, Dickersin R. Solitary fibrous tumor of the pleura. Eight new cases and review of 360 cases in the literature. Cancer. 1981;47:2678–89.

    PubMed  CAS  Google Scholar 

  125. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640–58.

    PubMed  CAS  Google Scholar 

  126. Westra WH, Gerald WL, Rosai J. Solitary fibrous tumor: consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol. 1994;18:992–8.

    PubMed  CAS  Google Scholar 

  127. Chilosi M, Facchetti F, Dei Tos AP, et al. bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol. 1997;181:362–7.

    PubMed  CAS  Google Scholar 

  128. Said JW, Nash G, Banks-Schlegel S, et al. Localized fibrous mesothelioma: an immunohistochemical and electron microscopic study. Hum Pathol. 1984;15:440–3.

    PubMed  CAS  Google Scholar 

  129. Moran CA, Suster S, Koss MN. The spectrum of histopathologic growth patterns in benign and malignant fibrous tumors of the pleura. Semin Diagn Pathol. 1992;9:169–80.

    PubMed  CAS  Google Scholar 

  130. McDougall A, McGarrity G. Extra-abdominal desmoid tumors. J Bone Joint Surg Br. 1979;61:373–7.

    PubMed  Google Scholar 

  131. Brodsky JT, Gordon MS, Hajdu SI, et al. Desmoid tumors of the chest wall: a locally recurrent problem. J Thorac Cardiovasc Surg. 1992;104:900–3.

    PubMed  CAS  Google Scholar 

  132. Varghese TK, Gupta R, Yeldandi AV, et al. Desmoid tumor of the chest wall with pleural involvement. Ann Thorac Surg. 2003;76:937–9.

    PubMed  Google Scholar 

  133. Andino L, Cagle PT, Murer B, et al. Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of B-catenin and cyclin D1 expression. Arch Pathol Lab Med. 2006;130:1503–9.

    PubMed  CAS  Google Scholar 

  134. Wilson RW, Gallateau-Salle F, Moran CA. Desmoid tumors of the pleura: a clinicopathologic mimic of localized fibrous tumor. Mod Pathol. 1999;12:9–14.

    PubMed  CAS  Google Scholar 

  135. Fetsch JF, Montgomery EA, Meis JM. Calcifying fibrous pseudotumor. Am J Surg Pathol. 1993;17:502–8.

    PubMed  CAS  Google Scholar 

  136. Van Dorpe J, Ectors N, Geboes K, et al. Is calcifying fibrous tumor pseudotumor a late sclerosing stage of inflammatory myofibroblastic tumor? Am J Surg Pathol. 1999;23:329–35.

    PubMed  Google Scholar 

  137. Nascimiento AF, Ruiz R, Hornick JL, et al. Calcifying fibrous “pseudotumor” clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor. Int J Surg Pathol. 2002;10:189–96.

    Google Scholar 

  138. Reed MK, Margraf LR, Nikaidoh H, et al. Calcifying fibrous pseudotumor of the chest wall. Ann Thorac Surg. 1996;62:873–4.

    PubMed  CAS  Google Scholar 

  139. Maeda T, Hirose T, Furuya K, Kameoka K. Calcifying fibrous pseudotumor: an ultrastructural study. Ultrastruct Pathol. 1999;23:189–92.

    PubMed  CAS  Google Scholar 

  140. Soyer T, Ciftci AO, Gucer S, et al. Calcifying fibrous pseudotumor of the lung: a previously unreported entity. J Pediatr Surg. 2004;39:1729–30.

    PubMed  Google Scholar 

  141. Pinkard NB, Wilson RW, Lawless N, et al. Calcifying fibrous pseudotumor of the pleura: a report of three cases of a newly described entity involving the pleura. Am J Clin Pathol. 1996;105:189–94.

    PubMed  CAS  Google Scholar 

  142. Hainaut P, Lesage V, Weynand B, et al. Calcifying fibrous pseudotumor (CFPT): a patient presenting with multiple pleural lesions. Acta Clin Belg. 1999;54:162–4.

    PubMed  CAS  Google Scholar 

  143. Mito K, Kashima K, Daa T, et al. Multiple calcifying fibrous tumor of the pleura. Virchows Arch. 2005;446:78–81.

    PubMed  Google Scholar 

  144. Ammar A, El Hammami S, Horchani H, et al. Calcifying fibrous pseudotumor of the pleura: a rare location. Ann Thorac Surg. 2003;76:2081–2.

    PubMed  Google Scholar 

  145. Jang KS, Oh YH, Han HX, et al. Calcifying fibrous pseudotumor of the pleura. Ann Thorac Surg. 2004;78:87–8.

    Google Scholar 

  146. Kawahara K, Yasukawa M, Nakagawa K, et al. Multiple calcifying fibrous tumor of the pleura. Virchows Arch. 2005;447:1007–8.

    PubMed  Google Scholar 

  147. Shibata K, Yuki D, Sakata K. Multiple calcifying fibrous pseudotumors disseminated in the pleura. Ann Thorac Surg. 2008;85:3–5.

    Google Scholar 

  148. Suh JH, Shin OR, Kim YH. Multiple calcifying fibrous pseudotumor of the pleura. J Thorac Oncol. 2008;3:1356–8.

    PubMed  Google Scholar 

  149. Erasmus JJ, McAdams P, Patz EF, et al. Calcifying fibrous pseudotumor of pleura: radiologic features in three cases. J Comput Assist tomogr. 1996;20:763–5.

    PubMed  CAS  Google Scholar 

  150. Zamecnik M, Michal M, Boudova L, Sulc M. CD34 expression in calcifying fibrous pseudotumours. Histopathology. 2000;36:182–91.

    Google Scholar 

  151. Adams AL, Castro CY, Singh P, Moran CA. Primary amyloidosis of the pleura mimicking mesothelioma. Ann Diagn Pathol. 2001;5:229–32.

    PubMed  CAS  Google Scholar 

  152. Moran CA, Suster S, Koss MN. Smooth muscle tumours presenting as pleural neoplasms. Histopathology. 1995;27:227–34.

    PubMed  CAS  Google Scholar 

  153. Gaertner E, Zeren EH, Fleming MV, et al. Biphasic synovial sarcomas arising in the pleural cavity. A clinicopathologic study of five cases. Am J Surg Pathol. 1996;20:36–45.

    PubMed  CAS  Google Scholar 

  154. Angerval L, Enzinger FM. Extra skeletal neoplasms resembling Ewing’s sarcoma. Cancer. 1977;101:446–9.

    Google Scholar 

  155. Askin FB, Rosai J, Sibley R, Dehner LP, et al. Malignant small cell tumors of the thoracopulmonary region in children. Cancer. 1979;43:2438–51.

    PubMed  CAS  Google Scholar 

  156. Gould V, Jannson D, Warren W. Primitive neuroectodermal tumors (PNET) of the chest wall in adults. Mod Pathol. 1991;4:115A (Abstract 681).

    Google Scholar 

  157. Hashimoto H, Enjoji M, Nakajima T, et al. Malignant neuroepithelioma (peripheral neuroblastoma). Am J Surg Pathol. 1983;7:309–18.

    PubMed  CAS  Google Scholar 

  158. Lane S, Ironside JW. Extraskeletal Ewing’s sarcoma of the nasal fossa. J Laryngol Otol. 1990;104:570–3.

    PubMed  CAS  Google Scholar 

  159. Soule EH, Newton W, Moon TE, et al. Extraskeletal Ewing’s ­sarcoma. A preliminary review of 26 cases encountered in the intergroup rhabdomyosarcoma study. Cancer. 1978;42:259–64.

    PubMed  CAS  Google Scholar 

  160. Suster S, Ronnen M, Huczar M. Extraskeletal Ewing’s sarcoma of the scalp. Pediatr Dermatol. 1988;5:126–8.

    Google Scholar 

  161. Tefft M, Vawter GF, Metus A. Paravertebral “round cell” tumors in children. Radiology. 1969;92:1501–9.

    PubMed  CAS  Google Scholar 

  162. Wigger JH, Salazar G, Blanc WA. Extraskeletal Ewing’s sarcoma. Arch Pathol Lab Med. 1977;101:446–9.

    PubMed  CAS  Google Scholar 

  163. Fujii Y, Hongo T, Nakagawa Y, et al. Cell culture of small round cell tumor originating in the thoracopulmonary region, evidence for derivation from a primitive pluripotent cell. Cancer. 1989;64:43–51.

    PubMed  CAS  Google Scholar 

  164. Yunis EJ, Agostini RM, Walpusk JA, et al. Glycogen in neuroblastomas. Am J Surg Pathol. 1979;3:199–208.

    Google Scholar 

  165. Guillespie JJ, Roth LM, Wills ER, et al. Extraskeletal Ewing’s sarcoma. Am J Surg Pathol. 1979;3:99–108.

    Google Scholar 

  166. Schmidt D, Mackay B, Ayala A. Ewing’s sarcoma with neuroblastoma like features. Ultrastruct Pathol. 1982;3:99–108.

    Google Scholar 

  167. Tsuji S, Hisaoka M, Morimitsu Y, et al. Peripheral primitive neuroectodermal tumour of the lung: report of two cases. Histopathology. 1998;33:369–74.

    PubMed  CAS  Google Scholar 

  168. Kahn AG, Avagnina A, Nazar J, et al. Primitive neuroectodermal tumor of the lung. Arch Pathol Lab Med. 2001;125:397–9.

    PubMed  CAS  Google Scholar 

  169. Mikami Y, Nakajima M, Hashimoto H, et al. Primary pulmonary primitive neuroectodermal tumor (PNET): a case report. Pathol Res Pract. 2001;197:113–9.

    PubMed  CAS  Google Scholar 

  170. Imamura F, Funakoshi T, Nakamura S, et al. Primary primitive neuroectodermal tumor of the lung. Report of two cases. Lung Cancer. 2000;27:55–60.

    PubMed  CAS  Google Scholar 

  171. Linnoila RI, Tsokos M, Triche TJ, et al. Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region (“Askin’s tumor”). Am J Surg Pathol. 1986;10:124–33.

    PubMed  CAS  Google Scholar 

  172. Tsokos M, Linnoila RI, Chandra RS, et al. Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round cell tumors in children. Hum Pathol. 1984;15:575–84.

    PubMed  CAS  Google Scholar 

  173. Gonzales-Crussi F, Wolfson SL, Misugi K, et al. Peripheral neuroectodermal tumors of the chest wall in childhood. Cancer. 1984;54:2519–27.

    Google Scholar 

  174. Ordonez NG. Application of immunohistochemistry in the diagnosis of soft tissue sarcomas: a review and update. Adv Anat Pathol. 1998;5(2):67–85.

    PubMed  CAS  Google Scholar 

  175. Hill DA, Pfeifer JD, Marley EF, et al. WT1 staining reliability differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor: an immunohistochemical and molecular diagnostic study. Am J Clin Pathol. 2000;114:345–53.

    PubMed  CAS  Google Scholar 

  176. Miettinen M, Chatten J, Paetau A, Stevenson A. Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors. Am J Surg Pathol. 1998;22:327–32.

    PubMed  CAS  Google Scholar 

  177. Batsakis JG, El-Nagar A. Ewing’s sarcoma and primitive neuroectodermal tumors: cytogenetic cynosures seeking a common ­histogenesis. Adv Anat Pathol. 1997;4(4):207–20.

    Google Scholar 

  178. Brown NP, Reid MM, Malcolm AJ, et al. Cytogenetic abnormalities of small round cell tumours. Med Pediatr Oncol. 1994;23:124–9.

    Google Scholar 

  179. Peng JW, Triche TJ, Knutsen T, et al. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet. 1986;21:185–208.

    Google Scholar 

  180. Contesso G, Llombart-Bosch A, Terrier P, et al. Does malignant small round cell tumor of the thoracopulmonary region (Askin tumor) constitute a clinicopathologic entity? An analysis of 30 cases with immunohistochemical and electron-microcopy support treated at the Institute Gustave Roussy. Cancer. 1992;69:1012–20.

    PubMed  CAS  Google Scholar 

  181. Falconieri G, Bussani R, Mirra M, Zanella M. Pseudomesotheliomatous angiosarcoma: a pleuropulmonary lesion simulating malignant pleural mesothelioma. Histopathology. 1997;30:419–24.

    PubMed  CAS  Google Scholar 

  182. Chen L, Shih HJ, Seguerra E, Lin JH. Pathologic quiz case: a 39-year-old man with diffuse pleural thickening and massive hemothorax. Arch Pathol Lab Med. 2004;128:1299–300.

    PubMed  Google Scholar 

  183. Pramesh CS, Madur BP, Raina S, et al. Angiosarcoma of the pleura. Ann Thorac Cardiovasc Surg. 2004;10:187–90.

    PubMed  CAS  Google Scholar 

  184. Maglaras GC, Katsenos S, Kakadelis J, et al. Primary angiosarcoma of the lung and pleura. Monaldi Arch Chest Dis. 2004;61:234–6.

    PubMed  CAS  Google Scholar 

  185. Liu SF, Hsieh MJ. Massive hemoptysis and hemothorax caused by pleuropulmonary angiosarcoma. Am J Emerg Med. 2002;20:374–5.

    PubMed  Google Scholar 

  186. Alexiou C, Clelland CA, Robinson D, Morgan WE. Primary angiosarcomas of the chest wall and pleura. Eur J Cardiothorac Surg. 1998;14:523–6.

    PubMed  CAS  Google Scholar 

  187. Roh MS, Seo JY, Hong SH. Epithelioid angiosarcoma of the pleura: a case report. J Korean Med Sci. 2001;16:792–5.

    PubMed  CAS  Google Scholar 

  188. Kimura M, Ito H, Furuta T, et al. Pyothorax-associated angiosarcoma of the pleura with metastasis to the brain. Pathol Int. 2003;53:547–51.

    PubMed  Google Scholar 

  189. Aozasa K, Naka N, Tomita Y, et al. Angiosarcoma developing from chronic pyothorax. Mod Pathol. 1994;7:906–11.

    PubMed  CAS  Google Scholar 

  190. Del Frate C, Mortele K, Zanardi R, et al. Pseudomesotheliomatous angiosarcoma of the chest wall and pleura. J Thorac Imaging. 2003;18:200–3.

    PubMed  Google Scholar 

  191. Zhang PJ, Livolvsi VA, Brooks JJ. Malignant epithelioid vascular tumors of the pleura: report of a series and literature review. Hum Pathol. 2000;31:29–34.

    PubMed  CAS  Google Scholar 

  192. Crotty EJ, McAdams HP, Erasmus JJ, et al. Epithelioid hemangioendothelioma of the pleura: clinical and radiological features. AJR Am J Roentgenol. 2000;175:1545–9.

    PubMed  CAS  Google Scholar 

  193. Bevelaqua FA, Valensi Q, Hulnick D. Epithelioid hemangioendothelioma: a rare tumor with variable prognosis presenting as a pleural effusion. Chest. 1988;93:665–6.

    PubMed  CAS  Google Scholar 

  194. Attanos RL, Suvarna SK, Rhead E, et al. Malignant tumours of the pleura in “asbestos” workers and endothelial differentiation in malignant mesothelioma. Thorax. 2000;55:860–3.

    Google Scholar 

  195. Pinet C, Magnan A, Garbe L, et al. Aggressive form of pleural epithelioid hemangioendothelioma: complete response after chemotherapy. Eur Respir J. 1999;14:237–8.

    PubMed  CAS  Google Scholar 

  196. Al-Shraim M, Mahboub B, Nelligan PC, et al. Primary pleural epithelioid hemangioendothelioma with metastases to the skin. A case report and literature review. J Clin Pathol. 2005;58:107–9.

    PubMed  CAS  Google Scholar 

  197. Lin BTY, Colby T, Gown AM, et al. Malignant vascular tumors of the serous membranes mimicking ­mesothelioma: a report of 14 cases. Am J Surg Pathol. 1996;20:1431–9.

    PubMed  CAS  Google Scholar 

  198. Saqi A, Nisbet L, Gagneja P, Leslie KO. Primary pleural epithelioid hemangioendothelioma with rhabdoid phenotype: report and review of the literature. Diagn Cytopathol. 2007;35:203–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Annikka Weissferdt M.D., FRCPath & Cesar A. Moran M.D.

Authors
  1. Annikka Weissferdt M.D., FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cesar A. Moran M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Weissferdt, A., Moran, C.A. (2013). Tumors of the Pleura. In: Diagnostic Pathology of Pleuropulmonary Neoplasia. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0787-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0787-5_12

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-0786-8

  • Online ISBN: 978-1-4419-0787-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation